TumVol Cancer Research Results

TumVol, Tumor Volume: Click to Expand ⟱
Source:
Type:
Tumor Volume
Scientific Papers found: Click to Expand⟱
8102- KAE,    Kaempferol inhibits gastric cancer tumor growth: An in vitro and in vivo study
- vitro+vivo, GC, MKN-28 - vitro+vivo, GC, SGC-7901 - in-vitro, GC, GES-1
TumCP↓, TumCCA↑, Apoptosis↑, selectivity↑, TumVol↓, CycB/CCNB1↓, CDK1↓, CDC25↓, Bcl-2↓, BAX↑, Casp3↑, Casp9↑, cl‑PARP↑, p‑Akt↓, p‑ERK↓, COX2/PTGS2↓,
8074- KAE,    Dose-dependent tuning of HSP70-Beclin-1 by kaempferol governs autophagy and chemosensitivity
- in-vitro, SCC, KYSE150 - in-vitro, SCC, KYSE450 - in-vitro, CRC, HCT116 - in-vitro, Liver, HepG2 - in-vitro, Cerv, HeLa - in-vitro, Lung, A549
ChemoSen⇅, HSP70/HSPA5↑, Beclin-1/ATG6⇅, Dose↝, TumVol⇅, TumW⇅,
9066- L-THE,    Chemoprotective effect of theanine in 1,2-dimethylhydrazine-induced colorectal cancer in rats via suppression of inflammatory parameters
- in-vivo, CRC, NA
*antiOx↑, *Inflam↓, Dose↝, Weight↑, TumVol↓, PGE2↓, COX2/PTGS2↓, MPO↓, *ROS↓, *MDA↓, *SOD↑, *GPx↑, *Catalase↑, *GSR↑, *LDH↓, *CEA↓, *MAPK↓, *Casp3↓, *Casp9↓, *Casp8↓, chemoP↑,
9006- L-THE,    Theanine from tea and its semi-synthetic derivative TBrC suppress human cervical cancer growth and migration by inhibiting EGFR/Met-Akt/NF-κB signaling
- vitro+vivo, Cerv, HeLa
TumCG↓, TumCMig↓, EZH2↓, TumCG↓, toxicity↓, Dose?, TumVol↓,
8176- Las,    In Vitro and In Vivo Anti-Cancer Activity of Lasiokaurin in a Triple-Negative Breast Cancer Model
- vitro+vivo, BC, NA
TumCCA↑, Apoptosis↑, DNAdam↑, TumMeta↓, PI3K↓, Akt↓, mTOR↓, STAT3↓, TumVol↓, toxicity↓,
8256- LCA,    Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice
- in-vivo, Colon, CT26
TumVol?, TumCP↓, *RenoP↑, *creat↓, BUN↓, hepatoP↑, *ALAT↓, *AST↓, *NO↓, *lipid-P↓, *GSH↑, chemoP↑, Dose↝,
8233- LCA,    Licochalcone A induces cell cycle arrest and apoptosis via suppressing MAPK signaling pathway and the expression of FBXO5 in lung squamous cell cancer
- in-vitro, Lung, NA
TumCP↓, selectivity↑, TumCCA↑, Apoptosis↑, cycD1/CCND1↓, cycE/CCNE↓, CDK2↓, CDK4↓, BAX↑, PARP1↑, Casp3↑, Bcl-2↓, MAPK↓, FBXO5/EMI1↓, TumVol↓, TumW↓, toxicity↓,
1040- LE,    Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8+ T cell infiltration
- in-vivo, Lung, H1975
TumCCA↑, CDK4↓, cycD1/CCND1↓, PD-L1↑, TumVol↓,
8195- LGE,    In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity
- vitro+vivo, BC, 4T1
TumCD↑, Dose↝, TumVol↓, cl‑Casp3↑, β-catenin/ZEB1↑, ALDH↓, Wnt↓,
8302- lign,    The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth
- vitro+vivo, BC, E0771 - in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7
Dose↝, TumVol↓, p‑p65↓, NF-kB↓, tumCV↓, Inflam↓,
8311- lign,    The Power of Lignans: Plant Compounds with Multifaceted Health-Promoting Effects
- Review, Nor, NA
*cardioP↑, *AntiDiabetic↑, *Obesity↓, *Bacteria↓, *AntiFungal↑, *AntiViral↑, *neuroP↑, *antiOx↑, *lipid-P↓, *memory↑, *CREB↑, *BDNF↑, *PSD95↑, *β-Amyloid↓, *TNF-α↓, *IL6↓, *IL10↓, *GutMicro↑, *Endoglin↑, *END↑, *cognitive↑, *Akt↓, *IκB↓, *NF-kB↓, *HO-1↑, *VEGF↑, *p‑eNOS↑, *GRP78/BiP↓, *PERK↓, *ATF4↓, *CHOP/DDIT3↓, *SREBP1/SREBF1↓, *ROS↓, TumVol↓,
8397- LT,    Effects and Mechanisms of Luteolin, a Plant-Based Flavonoid, in the Prevention of Cancers via Modulation of Inflammation and Cell Signaling Molecules
- Review, Var, NA
tumCV↓, TumCP↓, angioG↓, TumCI↓, TumMeta↓, mTOR↓, PI3K↓, Akt↓, STAT3↓, Wnt↓, β-catenin/ZEB1↓, TumCCA↑, Apoptosis↑, hTERT/TERT↓, AP-1↓, NF-kB↓, MAPK↓, HSP90↓, AR↓, IGF-1R↓, Akt↓, NOTCH↓, IL6↓, MMP2↓, MMP3↓, MMP9↓, MMP16↓, TumVol∅, TumW∅, miR-34a↑, miR-107↑, miR-139-5p↑, miR-422a↑, miR-21↓, miR-155↓, miR-224↓, miR-340↓, *toxicity↓,
8371- LT,    Study on the regulatory mechanism of luteolin inhibiting WDR72 on the proliferation and metastasis of non small cell lung cancer
- vitro+vivo, Lung, A549 - in-vitro, Lung, H1299 - in-vitro, Nor, BEAS-2B
TumCP↓, TumCI↓, TumCMig↓, TumVol↓, p‑Akt↓, Apoptosis↓, EMT↓, Dose↝, Akt↓, WDR72↓, TumMeta↓,
1041- Lyco,  immuno,    Lycopene improves the efficiency of anti-PD-1 therapy via activating IFN signaling of lung cancer cells
- in-vivo, Lung, NA
TumVol↓, TumW↓, eff↑, IL1↑, IFN-γ↑, IL4↓, IL10↓,
8509- MAG,  Rad,    The In Vivo Radiosensitizing Effect of Magnolol on Tumor Growth of Hepatocellular Carcinoma
- in-vivo, HCC, NA
TumVol↓, TumW↓, *ERK↓, *NF-kB↓, Casp3↑, Casp9↑, RadioS↑, *toxicity↓, Ki-67↓, IL1β↓, TNF-α↓,
8557- Matr,    Effects of matrine in combination with cisplatin on liver cancer
- in-vivo, Liver, HepG2
ChemoSen?, TumW↓, TumVol↓, survivin↓, XIAP↓, Casp3↑, Casp7↑, Casp9↑,
8642- MBZ,    In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning
- vitro+vivo, CRC, HT-29 - NA, NA, MCF10
Dose↝, selectivity↑, Apoptosis↑, TumVol↓, TumW↓, OS↑, TumCP↓,
8643- MBZ,    Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, 4T1 - in-vitro, BC, SUM159
*toxicity↓, TumCP↓, Apoptosis↑, TumCCA↑, TumVol↓, TumMeta↓, ITGB4↓, CSCs↓, Dose↝, TumCMig↓,
8648- MBZ,    Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
- Review, Var, NA
angioG↓, MMPs↓, MDR1↓, TubPol↓, RadioS?, ChemoSen?, TumCG↓, TumMeta?, OS↑, BioAv↓, BioAv↑, BBB↑, mitA↑, HH↓, Shh↓, Synergy↑, Gli1↓, PTCH2↓, XIAP↓, cl‑PARP↑, Casp3↑, BRAF↓, MEK↓, SYN1↑, Cyt‑c↑, TumVol↓, VEGFR2/KDR/Flk1↓, VEGF↓, VCAM-1↓, DYRK1B↓, QoL↑, Dose↝,
2486- mCHEMO,  capec,    Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases
- Case Report, HCC, NA
OS↑, eff↝, Dose↝, AFP↓, Dose↝, TumVol↓, AFP↓,
2489- mCHEMO,  capec,    Long-lasting response with metronomic capecitabine in advanced hepatocellular carcinoma
- Case Report, HCC, NA
Dose↝, OS↑, TumVol↓, AFP↓,
2490- mCHEMO,    Durable complete response of hepatocellular carcinoma after metronomic capecitabine
- Case Report, HCC, NA
angioG↓, TumVol↓, Remission↑,
8823- MCP,    Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model
- in-vivo, CRC, CT26
TumMeta↓, Gal-3↓, TumVol↓, Dose↝,
8750- MeSA,    Methylseleninic acid restricts tumor growth in nude mice model of metastatic breast cancer probably via inhibiting angiopoietin-2
- vitro+vivo, BC, MDA-MB-231
ANGPT2↓, VEGF↓, TumVol↓, TumW↓,
5534- MF,    Targeted Osmotic Lysis of Highly Invasive Breast Carcinomas Using Pulsed Magnetic Field Stimulation of Voltage-Gated Sodium Channels and Pharmacological Blockade of Sodium Pumps
- vitro+vivo, BC, MDA-MB-231 - in-vitro, Nor, MCF10
TumVol↓, VGSC↑, OS↑, selectivity↑, eff↑,
2260- MF,    Alternative magnetic field exposure suppresses tumor growth via metabolic reprogramming
- in-vitro, GBM, U87MG - in-vitro, GBM, LN229 - in-vivo, NA, NA
TumCP↓, TumCG↓, OS↑, ROS↑, SOD2↑, eff↓, ECAR↓, OCR↑, selectivity↑, *toxicity∅, TumVol↓, PGC-1α↑, OXPHOS↑, Glycolysis↓, PKM2↓,
8491- MF,  Chemo,    Chemotherapy of human carcinoma xenografts during pulsed magnetic field exposure
- in-vivo, CRC, HT-29 - NA, Melanoma, A431
Dose↝, Dose↝, TumVol↓,
4092- MF,    Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology
- Review, Var, NA
Apoptosis↑, selectivity↑, ROS↑, Catalase↓, TumVol↓, angioG↓, Ca+2↝, eff↝, angioG↓, Imm↝, TNF-α↑, Casp8↑,
524- MF,    Inhibition of Angiogenesis Mediated by Extremely Low-Frequency Magnetic Fields (ELF-MFs)
- vitro+vivo, PC, MS-1 - vitro+vivo, PC, HUVECs
other↓, TumCP↓, TumCMig↓, VEGFR2/KDR/Flk1↓, TumVol↓, HSP70/HSPA5↓, HSP90↓, TumCCA↑, angioG↓,
497- MF,    In Vitro and in Vivo Study of the Effect of Osteogenic Pulsed Electromagnetic Fields on Breast and Lung Cancer Cells
- vitro+vivo, BC, MCF7 - vitro+vivo, Lung, A549
TumCG↓, TumVol↓, Casp3↑, Casp7↑, Apoptosis↑, DNAdam↑, TumCCA↑, ChemoSen↑, EPR↑,
511- MF,    Optimization of a therapeutic electromagnetic field (EMF) to retard breast cancer tumor growth and vascularity
- in-vivo, BC, NA
TumVol↓,
514- MF,    Therapeutic electromagnetic field effects on angiogenesis and tumor growth
- in-vivo, Var, NA
TumVol↓,
4354- MF,  doxoR,    Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach
- in-vivo, BC, MDA-MB-231 - in-vivo, BC, MCF7
selectivity↑, Apoptosis↑, TumCI↓, tumCV↓, TumVol↓, eff↓, ChemoSen↑, ROS↑, Ca+2↑, TumCMig↓,
9268- MFrot,    EXTH-13. Inhibition of mitochondrial electron transport, induction of oxidative stress, and DNA damage by oncomagnetic device in GBM cancer cells
- Review, GBM, NA
TumVol↓, OS↑, DNAdam↑, γH2AX↑, toxicity↓, compI↓, ROS↑, selectivity↑, TumCCA↑, eff↓,
8479- MFrot,  doxoR,    Dual-targeting by rotating magnetic field-driven superparamagnetic bionic nanorobots for enhanced triple-negative breast cancer therapy
- vitro+vivo, BC, 4T1
Dose?, EPR↑, BioEnh↑, GSH↓, GPx4↓, Iron↑, ROS↑, lipid-P↑, Ferroptosis↑, TumVol↓, Fenton↑,
2258- MFrot,  MF,    EXTH-68. ONCOMAGNETIC TREATMENT SELECTIVELY KILLS GLIOMA CANCER CELLS BY INDUCING OXIDATIVE STRESS AND DNA DAMAGE
- in-vitro, GBM, GBM - in-vitro, Nor, SVGp12
TumVol↓, OS↑, γH2AX↑, DNAdam↑, selectivity↑, ROS↑, TumCD↑, eff↑, eff↓,
187- MFrot,  MF,    Method for noninvasive whole-body stimulation with spinning oscillating magnetic fields and its safety in mice
- in-vivo, GBM, NA
selectivity↑, ROS↑, *ROS∅, *toxicity∅, ETC↓, TumVol↓, Dose↝,
185- MFrot,  MF,    Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device
- Human, GBM, NA
TumVol↓, Dose↝, cognitive↑,
215- MFrot,  MF,    Magneto-mechanical destruction of cancer-associated fibroblasts using ultra-small iron oxide nanoparticles and low frequency rotating magnetic fields
- in-vitro, PC, CAF
TumVol↓, lysoMP↑, CAFs/TAFs↓, eff↑,
203- MFrot,  MF,    Rotating Magnetic Field Induced Oscillation of Magnetic Particles for in vivo Mechanical Destruction of Malignant Glioma
- vitro+vivo, GBM, U87MG
lysoMP↓, TumVol↓, eff↑, Apoptosis↑, Ca+2↑,
200- MFrot,  MF,    Moderate intensity low frequency rotating magnetic field inhibits breast cancer growth in mice
- in-vivo, BC, MDA-MB-231 - in-vivo, BC, MCF7
ALAT↓, TumVol↓, TumCCA↑, TumCG↓, TumMeta↓, Imm↑, P53↑, ALAT↓, AST↓,
516- MFrot,  immuno,  MF,    Anti-tumor effect of innovative tumor treatment device OM-100 through enhancing anti-PD-1 immunotherapy in glioblastoma growth
- vitro+vivo, GBM, U87MG
TumCP↓, Apoptosis↑, TumCMig↓, ROS↑, PD-L1↑, TumVol↓, eff↑, *toxicity∅, eff↑, *toxicity∅, Dose↝, tumCV↓, TumCI↓,
9073- MGF,    Mangiferin induces apoptosis in multiple myeloma cell lines by suppressing the activation of nuclear factor kappa B-inducing kinase
- in-vitro, MM, NA
TumVol↓, Apoptosis↑, Casp3↑, MMP↓, NF-kB↓, IκB↑, XIAP↓, survivin↓, Bcl-xL↓,
9075- MGF,    Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway
- vitro+vivo, BC, MDA-MB-231
tumCV↓, TumMeta↓, MMP7↓, MMP9↓, EMT↓, β-catenin/ZEB1↓, TumVol↓, TumW↓, TumCP↓, Apoptosis↑, Vim↓, E-cadherin↑,
1779- MLT,    Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review
- Review, BC, NA
QoL↑, OS↑, Dose∅, antiOx↑, ROS↑, SOD↑, Catalase↑, GPx↑, Risk↓, NK cell↑, IL1β↓, IL6↓, TNF-α↓, radioP↑, chemoP↑, TumVol↓, TumMeta↓, angioG↓, ChemoSen↑, eff↑,
8662- MLT,    Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis
- vitro+vivo, Bladder, 5637 - in-vitro, CRC, T24/HTB-9 - in-vitro, HNSCC, UM-SCC-1
Glycolysis↓, ENO1↓, ROS↑, TumCP↓, TumMeta↓, TumCCA↑, Casp3↑, BIM↑, Bcl-2↓, γH2AX↑, EMT↓, N-cadherin↓, MMP9↓, Snail↓, Akt↓, eff↓, TumVol↓, PPARγ↓,
8673- MLT,    Therapeutic Potential of Melatonin in Gastrointestinal Cancers: Molecular Mechanisms, Preclinical Evidence and Clinical Implications
- Review, GC, NA
ChemoSen↑, TumVol↓, β-catenin/ZEB1↓, Risk↓, radioP↑, Mucositis↓, Dose↝, toxicity↓, BioAv↓, *antiOx↑, *SOD↑, *GPx↑, *Catalase↑, *NRF2↑, Apoptosis↑, Estro↝, Telomerase↓, *ROS↓, angioG↓, Imm↑, TumCCA↑, Glycolysis↓, OXPHOS↑, mTORC1↓, VEGF↓, Hif1a↓, ROS↓, TumAuto↓, HSP70/HSPA5↓, PI3K↓, Akt↓, mTOR↓, BAX↑, Casp↑, Cyt‑c↑, tumCV↓, TumCMig↓, TumCI↓, TumVol↓, TumW↓, P21↑, P53↑, Synergy↑, ER Stress↑, Synergy↑, RadioS↑, eff↑, eff↑, fatigue↓, Sleep↑,
8683- MLT,    Intra-tumor ROS amplification by melatonin interferes in the apoptosis-autophagy-inflammation-EMT collusion in the breast tumor microenvironment
- in-vivo, BC, NA
ROS↑, SIRT1↑, IL6↓, STAT3↓, NF-kB↓, PI3K↓, Akt↓, mTOR↓, TumCP↓, tumCV↓, JNK↑, P53↑, Bax:Bcl2↑, cl‑Casp3↑, Apoptosis↑, eff∅, TumAuto↑, EMT↓, Half-Life↓, CompStab↓, BioAv↓, Dose↝, TumW↓, TumVol↓, Ki-67↓, PTEN↑,
8611- MO,    Antitumoral effects of Melissa officinalis on breast cancer in vitro and in vivo
- vitro+vivo, BC, MCF7 - in-vitro, BC, MDA-MB-231 - in-vitro, BC, MDA-MB-468
Casp7↑, Ki-67↓, TumVol↓,
8879- MOR,  doxoR,    Synergistic Effects of Morin and Doxorubicin Overcome Chemoresistance in Ovarian Cancer: Preclinical Insights From in vitro and in vivo Models
- vitro+vivo, Ovarian, OVCAR-3 - NA, Melanoma, A2780S
Dose↝, ChemoSen↑, cycA1/CCNA1↓, cycD1/CCND1↓, TumVol↓, Apoptosis↑, TumCCA↑, ROS↝, chemoP↑, TumAuto↑, ROS↓, SOD↑, Catalase↑, GSH↑, MDA↓, cardioP↑, mTOR↓, PI3K↓, Akt↓, Bcl-2↓, Casp3↑, Casp9↑, LC3A↑, ATG5↑, Beclin-1/ATG6↑,

Showing Research Papers: 151 to 200 of 249
Prev Page 4 of 5 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 249

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 3,   Catalase↓, 2,   Catalase↑, 2,   Fenton↑, 2,   GCLM↓, 1,   GPx↑, 1,   GPx1↓, 1,   GPx4↓, 4,   GSH↓, 7,   GSH↑, 1,   GSH/GSSG↓, 1,   GSTs↓, 1,   H2O2↑, 1,   HO-1↓, 2,   HO-1↑, 1,   hyperG↓, 1,   Iron↑, 4,   Iron∅, 1,   i-Iron↑, 1,   lipid-P↑, 4,   MDA↓, 1,   MDA↑, 4,   MPO↓, 1,   NQO1↑, 1,   NRF2↓, 2,   NRF2↑, 1,   NRF2↝, 1,   RNS↑, 1,   ROS↓, 4,   ROS↑, 59,   ROS↝, 1,   mt-ROS↑, 3,   SOD↓, 2,   SOD↑, 2,   SOD2↓, 2,   SOD2↑, 2,   TAC↓, 1,   TrxR1↓, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↓, 2,   NCOA4↑, 1,   TfR1/CD71↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   CDC25↓, 3,   compI↓, 2,   ETC↓, 1,   HSP60/HSPD1↓, 2,   mitResp↓, 1,   mtDam↑, 3,   OCR↓, 2,   OCR↑, 2,   OXPHOS↑, 3,   mt-OXPHOS↑, 1,   PDH↑, 1,   PGC-1α↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   ACC↑, 1,   ALAT↓, 3,   ALAT↑, 1,   ALDOAiso2↓, 1,   AMPK↓, 1,   AMPK↑, 2,   p‑AMPK↑, 2,   ATP↓, 3,   ATP↝, 1,   DHA↑, 1,   ECAR↓, 1,   ENO1↓, 1,   GAPDH↓, 1,   GlucoseCon↓, 4,   Glycolysis↓, 12,   Glycolysis↑, 1,   GSK‐3β↓, 2,   GSK‐3β↑, 1,   p‑GSK‐3β↓, 1,   p‑GSK‐3β↑, 2,   HK2↓, 7,   HMG-CoA↓, 1,   lactateProd↓, 7,   LDHA↓, 2,   lipoGen↓, 1,   NAD↓, 1,   PDK1 / PDPK1↓, 1,   PDKs↓, 1,   PFK↓, 1,   PFK1↓, 1,   PGK1↓, 1,   PKM2↓, 6,   PLA2↓, 1,   Pyrim↓, 1,   SCD1↓, 1,   SIRT1↓, 1,   SIRT1↑, 1,   TS↓, 1,   Warburg↓, 4,  

Cell Death(tgid=5) ⓘ

AIF↑, 1,   Apoptosis?, 1,   Apoptosis↓, 1,   Apoptosis↑, 84,   mt-Apoptosis↑, 2,   ASK1↑, 1,   BAD↓, 1,   Bak↑, 1,   BAX↑, 31,   Bax:Bcl2↑, 7,   Bcl-2↓, 44,   Bcl-2↑, 1,   Bcl-xL↓, 13,   BIM↑, 2,   Casp↑, 7,   proCasp↑, 1,   Casp1↑, 1,   Casp12↑, 1,   Casp3?, 1,   Casp3↓, 1,   Casp3↑, 39,   cl‑Casp3↑, 17,   proCasp3↑, 1,   Casp7?, 1,   Casp7↑, 4,   cl‑Casp7↑, 2,   Casp8↑, 8,   cl‑Casp8↑, 4,   Casp9?, 1,   Casp9↑, 19,   cl‑Casp9↑, 5,   cFLIP↓, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 11,   DR5↑, 1,   Endon↑, 1,   FasL↑, 2,   Ferroptosis↓, 1,   Ferroptosis↑, 6,   GSDMD↑, 1,   GSDME↑, 1,   IAP1↓, 2,   IAP2/BIRC3↓, 1,   ICD↑, 2,   iNOS↓, 2,   Mcl-1↓, 6,   MDM2↓, 2,   necrosis↑, 3,   p38↑, 2,   p‑p38↑, 4,   Pyro↑, 2,   survivin↓, 20,   TRAIL↑, 1,   TumCD↑, 13,   XIAP↓, 10,   XIAP↑, 1,   YAP/TEAD↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 28,   Akt↑, 3,   p‑Akt↓, 9,   AMPKα↓, 1,   AMPKα↑, 1,   BRAF↓, 1,   DYRK1B↓, 1,   EGFR↓, 3,   ERK↓, 6,   p‑ERK↓, 7,   p‑ERK↑, 1,   GNAI1↓, 1,   HER2/EBBR2↓, 1,   Hippo↓, 1,   IGF-1R↓, 3,   IKKα↓, 1,   IKKα↑, 1,   p‑IKKα↓, 2,   ILK↓, 1,   IR↓, 1,   IκB↓, 1,   IκB↑, 1,   JAK1↓, 2,   JAK2↓, 5,   JNK↓, 1,   JNK↑, 3,   p‑JNK↑, 3,   LIFR/CD118↓, 1,   MAPK↓, 6,   MAPK↑, 1,   MEK↓, 1,   mTOR↓, 14,   mTOR↑, 3,   p‑mTOR↓, 3,   p‑p70S6↓, 1,   P70S6K↓, 1,   PI3K↓, 23,   PI3K↑, 2,   p‑PI3K↓, 1,   p‑PI3k/Akt/mTOR↓, 1,   PIK3CA↑, 1,   PKA↓, 2,   PKCδ↓, 1,   PTEN↓, 1,   PTEN↑, 3,   Raf↓, 1,   SHP1↑, 1,   c-Src↓, 1,   STAT↓, 1,   STAT3↓, 19,   p‑STAT3↓, 3,   p‑STAT3↑, 2,   i-STAT3↓, 1,   STAT4↑, 1,   STAT5↓, 2,   TK1↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↑, 1,   cMyc↓, 5,   DNMT1↓, 2,   DNMT3B↓, 1,   EZH2↓, 2,   FOXM1↓, 1,   FOXO1↑, 1,   FOXO3↑, 1,   ac‑H3↑, 2,   ac‑H4↑, 2,   HDAC↓, 7,   HDAC1↓, 2,   HDAC2↓, 3,   HDAC3↓, 3,   IRF1↑, 1,   KCNQ1OT1↓, 1,   KLF2↓, 1,   KLF4↓, 1,   KLF5↓, 1,   miR-107↑, 1,   miR-124-3p↓, 1,   miR-139-5p↑, 1,   miR-155↓, 1,   miR-199↓, 1,   miR-21↓, 1,   miR-224↓, 1,   miR-340↓, 1,   miR-34a↑, 1,   miR-375↑, 1,   miR-422a↑, 1,   miR-497↑, 1,   OCT4↓, 5,   other↓, 2,   other↝, 10,   SALL4↓, 1,   SD↑, 1,   SOX2↓, 2,   TFE3↑, 1,   tumCV↓, 32,   tumCV↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 2,   eIF2α↑, 1,   ER Stress↓, 1,   ER Stress↑, 3,   GRP78/BiP↑, 3,   HSP70/HSPA5↓, 3,   HSP70/HSPA5↑, 1,   HSP90↓, 3,   HTRA↓, 2,   PERK↑, 1,   Proteasome↓, 1,   PSMB5↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

APA↑, 1,   ATG5↑, 3,   ATG5↝, 1,   ATG7↑, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 2,   Beclin-1/ATG6⇅, 1,   Beclin-1/ATG6↝, 1,   p‑Beclin-1/ATG6↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3A↑, 1,   LC3B↑, 1,   LC3B-II↓, 1,   LC3B-II↑, 1,   LC3I↑, 1,   LC3II↑, 1,   lysoMP↓, 1,   lysoMP↑, 1,   p62↓, 3,   p62↑, 2,   TumAuto↓, 2,   TumAuto↑, 17,   TumAuto↝, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↑, 13,   DNArepair↓, 1,   hTERT/TERT↓, 3,   NKX3.1↓, 1,   P53↑, 22,   i-P53↓, 1,   PARP↓, 1,   PARP↑, 2,   cl‑PARP↑, 21,   PARP1↑, 1,   cl‑PARP1↑, 3,   PCNA↓, 10,   PCNA↝, 1,   Telomerase↓, 1,   TOP2↓, 2,   γH2AX↑, 4,   p‑γH2AX↑, 2,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 4,   CDK2↓, 6,   CDK4↓, 7,   CDK4↑, 2,   CDK6↓, 1,   CDK6↑, 3,   CDKN1C/p57↑, 1,   Cyc↓, 2,   cycA1/CCNA1↓, 4,   CycB/CCNB1↓, 6,   cycD1/CCND1↓, 24,   cycD1/CCND1↑, 1,   cycE/CCNE↓, 3,   cycE1↓, 1,   E2Fs↓, 2,   FBXO5/EMI1↓, 1,   Ki-67↓, 23,   mitA↓, 1,   mitA↑, 2,   P21↓, 2,   P21↑, 15,   p27/CDKN1B↓, 1,   p27/CDKN1B↑, 4,   TubPol↓, 1,   TumCCA↑, 54,   UBE2C↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   ALDH↓, 4,   AXIN1↑, 1,   CD133↓, 2,   CD24↓, 1,   CSCs↓, 11,   CSCsMark↓, 1,   Diff↑, 1,   EP2↓, 1,   FGF↓, 2,   Gli1↓, 3,   HH↓, 4,   HH∅, 1,   IGF-1↓, 6,   Ki-67↓, 23,   LGR5↓, 1,   LRP6↓, 1,   p‑LRP6↓, 1,   mTORC1↓, 2,   Nanog↓, 2,   NOTCH↓, 1,   NOTCH1↓, 2,   NOTCH3↓, 1,   PTCH2↓, 1,   SCF↓, 1,   Shh↓, 3,   Smo↓, 1,   TumCG?, 1,   TumCG↓, 38,   TumCP↓, 59,   TumCP↑, 1,   WDR72↓, 1,   Wnt↓, 6,   Wnt/(β-catenin)↓, 2,  

Migration(tgid=13) ⓘ

ANGPT2↓, 1,   AP-1↓, 2,   Ca+2↓, 1,   Ca+2↑, 9,   Ca+2↝, 1,   CAFs/TAFs↓, 1,   Cdc42↓, 1,   Cdc42↑, 1,   COL1↓, 1,   E-cadherin↑, 10,   EMT↓, 17,   EpCAM↓, 2,   F-actin↓, 1,   p‑FAK↓, 1,   GLI3↓, 1,   hnRNPA1↓, 1,   ITGB4↓, 1,   MALAT1↓, 1,   MMP1↓, 1,   MMP16↓, 1,   MMP2↓, 15,   MMP3↓, 2,   MMP7↓, 2,   MMP9↓, 20,   MMPs↓, 3,   MUC1-C↓, 1,   MUC4↓, 1,   N-cadherin↓, 7,   PAI-1/SERPINE1↑, 1,   PAK1↑, 1,   Rho↓, 1,   serineP↓, 1,   Slug↓, 2,   p‑SMAD2↓, 1,   p‑SMAD3↓, 1,   Snail↓, 4,   TGF-β↓, 3,   TGF-β↑, 1,   TIMP1↓, 1,   TIMP1↑, 2,   TIMP2↑, 5,   TumCI↓, 26,   TumCMig↓, 38,   TumMeta?, 1,   TumMeta↓, 28,   Twist↓, 2,   uPA↓, 2,   Vim↓, 5,   Zeb1↓, 1,   α-SMA↓, 1,   α-SMA↑, 1,   β-catenin/ZEB1↓, 8,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 28,   CD31/PECAM-1↓, 3,   Endoglin↓, 1,   eNOS↓, 1,   HIF-1↓, 1,   Hif1a↓, 14,   NO↓, 1,   NO↑, 1,   VCAM-1↓, 2,   VEGF↓, 22,   VEGF↑, 1,   VEGFR2/KDR/Flk1↓, 2,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 3,   CellMemb↑, 1,   CLDN1↓, 1,   EPR↓, 1,   EPR↑, 4,   GLUT1↓, 3,   GLUT2↓, 1,   GLUT3↓, 1,   GLUT4↓, 1,   IBI↑, 1,   LAT↓, 1,   MMP↓, 23,   MMP↑, 1,   MPT↑, 1,   SLC12A5↓, 1,   SVCT-2↝, 1,   TRPM7↓, 1,   VGSC↑, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD44↓, 5,   CD47↓, 1,   CD8+↑, 3,   COX2/PTGS2↓, 16,   COX2/PTGS2↑, 1,   CXCR4↓, 2,   Gal-3↓, 1,   GM-CSF↓, 1,   HMGB1↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 1,   IFN-γ↑, 2,   IL1↑, 1,   IL10↓, 1,   IL18↓, 1,   IL1β↓, 8,   IL1β↑, 1,   IL4↓, 2,   IL6↓, 12,   IL7↓, 1,   IL8↓, 3,   Imm↑, 4,   Imm↝, 2,   Inflam↓, 4,   Macrophages↓, 1,   Neut↓, 1,   NF-kB↓, 31,   NF-kB↑, 1,   NK cell↑, 3,   NLRP3↑, 1,   p65↓, 4,   p‑p65↓, 3,   PD-L1↓, 1,   PD-L1↑, 2,   PGE1↓, 1,   PGE2↓, 2,   PSA↓, 8,   RANTES↓, 1,   SOCS1↑, 1,   T-Cell↑, 1,   TCF↝, 1,   TLR4↓, 1,   TNF-α↓, 8,   TNF-α↑, 2,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 1,   pH↑, 1,   pH∅, 1,   e-pH↓, 1,   e-pH↑, 1,   i-pH↓, 1,   Temp∅, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

ChE↓, 1,   SYN1↑, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↑, 1,   AR↓, 5,   AR-FL↓, 1,   AR-V7↑, 1,   CYP19↓, 1,   ER(estro)↓, 1,   Estro↝, 1,   FKBP5↓, 1,   PPARγ↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 9,   BioAv↑, 8,   BioAv↝, 4,   BioEnh↑, 2,   ChemoSen?, 2,   ChemoSen↑, 37,   ChemoSen⇅, 1,   CompStab↓, 1,   Dose?, 3,   Dose↓, 1,   Dose↑, 2,   Dose↝, 66,   Dose∅, 5,   eff↓, 27,   eff↑, 39,   eff↝, 6,   eff∅, 3,   GSTA1↓, 1,   GSTZ1↓, 1,   Half-Life↓, 3,   Half-Life↑, 1,   Half-Life↝, 2,   MDR1↓, 1,   P-gp/ABCB1↓, 2,   RadioS?, 1,   RadioS↑, 5,   RadioS↝, 1,   selectivity↑, 39,   Synergy↑, 29,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 3,   ALAT↓, 3,   ALAT↑, 1,   ALB↑, 1,   ALP↑, 1,   AR↓, 5,   ascitic↓, 1,   AST↓, 2,   AST↑, 1,   BG↓, 1,   BRAF↓, 1,   BUN↓, 1,   CA125↓, 1,   CEA↓, 1,   CYFRA21-1↓, 1,   E6↓, 1,   E7↓, 1,   EGFR↓, 3,   EZH2↓, 2,   FOXM1↓, 1,   HER2/EBBR2↓, 1,   hTERT/TERT↓, 3,   IL6↓, 12,   IRes↓, 1,   LDH↓, 1,   LDH↑, 2,   PD-L1↓, 1,   PD-L1↑, 2,   PSA↓, 8,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 15,   antiNeop↑, 1,   AntiTum↑, 9,   cardioP↑, 4,   chemoP↑, 12,   chemoPv↑, 4,   cognitive↑, 1,   fatigue↓, 2,   hepatoP↑, 4,   motorD↑, 1,   Mucositis↓, 1,   neuroP↑, 2,   NP/CIPN↓, 1,   OS↑, 33,   PFS↑, 1,   Pin1↓, 2,   QoL↑, 9,   radioP↑, 7,   Remission↑, 3,   Risk↓, 8,   Sleep↑, 1,   toxicity↓, 20,   toxicity↝, 2,   toxicity∅, 1,   TumNum↓, 2,   TumVol?, 1,   TumVol↓, 244,   TumVol↑, 3,   TumVol⇅, 1,   TumVol∅, 1,   TumW↓, 60,   TumW⇅, 1,   TumW∅, 1,   Weight↓, 2,   Weight↑, 7,   Weight∅, 3,  

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 1,   GutMicro↑, 3,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 1,   Ingr↝, 3,  
Total Targets: 605

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 10,   Catalase↑, 8,   Fenton↓, 1,   GPx↑, 4,   GPx1↑, 1,   GSH↑, 2,   GSR↑, 1,   GSTs↑, 3,   HDL↑, 1,   HO-1↑, 3,   lipid-P↓, 4,   MDA↓, 4,   MPO↓, 2,   NOX↓, 1,   NOX4↓, 1,   NRF2↑, 4,   RNS↓, 1,   ROS↓, 14,   ROS∅, 1,   SAM-e↑, 1,   SOD↑, 6,   SOD1↑, 1,   TAC↑, 1,   TBARS↓, 1,   VitE↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compII↑, 1,   compIII↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 1,   adiP↑, 1,   ALAT↓, 2,   ATP↑, 1,   ATP↝, 1,   FASN↓, 1,   glucose↓, 1,   LDL↓, 1,   NAD↝, 1,   NADPH↓, 1,   NH3↓, 1,   SREBP1/SREBF1↓, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 2,   Bcl-2↑, 1,   Bcl-xL↑, 1,   Casp12↓, 1,   Casp3↓, 3,   Casp8↓, 1,   Casp9↓, 2,   GranB/GZMB↓, 1,   p38↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   Akt↑, 2,   CREB↑, 1,   ERK↓, 1,   IκB↓, 1,   JAK2↑, 1,   p‑JNK↓, 1,   MAPK↓, 2,   mTOR↓, 1,   PI3K↑, 2,   PTEN↑, 1,   STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↓, 2,   HDAC↓, 1,   other↑, 1,   tumCV↓, 2,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 2,   p‑eIF2α↓, 1,   ER Stress↓, 2,   GRP78/BiP↓, 2,   PERK↓, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

LC3‑Ⅱ/LC3‑Ⅰ↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

BMPs↑, 1,   IGF-1↓, 1,   TumCP↓, 1,  

Migration(tgid=13) ⓘ

Ca+2↝, 1,   serineP↓, 1,   TGF-β↑, 1,   TumCI↓, 1,   TumCMig↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

Endoglin↑, 1,   p‑eNOS↑, 1,   Hif1a↑, 1,   NO↓, 2,   VEGF↑, 2,  

Barriers & Transport(tgid=15) ⓘ

IBI↑, 1,   MMP↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD25+↑, 1,   CD4+↑, 2,   COX2/PTGS2↓, 3,   FOXP3↑, 1,   HMGB1↓, 1,   IFN-γ↓, 1,   IL10↓, 1,   IL10↑, 2,   IL1β↓, 2,   IL4↓, 1,   IL4↑, 1,   IL6↓, 5,   Imm↑, 1,   Inflam↓, 12,   LPS↓, 1,   M2 MC↑, 1,   MCP1/CCL2↓, 1,   NF-kB↓, 6,   NLRP3↓, 2,   PGE2↓, 2,   TNF-α↓, 6,   Treg lymp↝, 1,   VitD↑, 2,  

Synaptic & Neurotransmission(tgid=18) ⓘ

BDNF↑, 2,   PSD95↑, 1,  

Protein Aggregation(tgid=19) ⓘ

APP↓, 1,   Aβ↓, 2,   BACE/β-secretase↓, 1,   β-Amyloid↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

END↑, 1,   FGF21↑, 1,   testos↑, 1,   TSHR↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 1,   BioAv↑, 7,   BioAv↝, 3,   Dose↓, 1,   Dose↑, 2,   Dose↝, 5,   eff↑, 5,   Half-Life↝, 2,   P450↓, 1,   selectivity↑, 1,   Synergy↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   AST↓, 2,   BMD↑, 1,   Calcium↑, 2,   CEA↓, 2,   creat↓, 2,   hs-CRP↓, 1,   IL6↓, 5,   LDH↓, 1,   Mag↑, 2,   SpO2↑, 1,   TC↓, 1,   Urea↓, 1,   VitD↑, 2,  

Functional Outcomes(tgid=23) ⓘ

antiAll↑, 2,   AntiCan↑, 2,   AntiDiabetic↑, 1,   antiPs↑, 1,   cardioP↑, 5,   chemoP↑, 1,   chemoPv↑, 1,   ChemoSideEff↓, 1,   cognitive↑, 5,   hepatoP↑, 2,   memory↓, 1,   memory↑, 3,   motorD↓, 1,   neuroP↑, 9,   Obesity↓, 3,   OS↑, 2,   RenoP↑, 2,   Risk↓, 1,   Stroke↓, 2,   toxicity↓, 12,   toxicity↝, 4,   toxicity∅, 7,   Weight↑, 1,   Weight∅, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiFungal↓, 1,   AntiFungal↑, 1,   AntiP↑, 1,   AntiViral↑, 1,   Bacteria↓, 3,   GutMicro↑, 3,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 2,  
Total Targets: 180

Scientific Paper Hit Count for: TumVol, Tumor Volume
16 Magnetic Fields
9 Silver-NanoParticles
9 doxorubicin
9 Magnetic Field Rotating
8 Curcumin
7 Quercetin
6 Hydrogen Gas
5 Apigenin (mainly Parsley)
5 Boron
5 EGCG (Epigallocatechin Gallate)
4 itraconazole
4 immunotherapy
4 Melatonin
4 Shikonin
4 Thymoquinone
3 Photodynamic Therapy
3 Vitamin C (Ascorbic Acid)
3 Ashwagandha(Withaferin A)
3 Betulinic acid
3 Radiotherapy/Radiation
3 Cisplatin
3 Dichloroacetate
3 5-fluorouracil
3 Evodiamine
3 Fenbendazole
3 Ginkgetin
3 Inositol
3 Ivermectin
3 mebendazole
3 MCT, metronomic chemo
3 Silymarin (Milk Thistle) silibinin
2 cetuximab
2 EMF
2 Gold NanoParticles
2 Allyl isothiocyanate
2 Allicin (mainly Garlic)
2 Baicalein
2 Berbamine
2 Berberine
2 Beta-Caryophyllene
2 Caffeic acid
2 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
2 Centella asiatica / Gotu kola → asiaticoside
2 Chlorogenic acid
2 Chrysin
2 Chemotherapy
2 Eugenol
2 Fisetin
2 Formononetin
2 Flaxseed Oil
2 Gallic acid
2 Orlistat
2 Hibiscus sabdariffa
2 Honokiol
2 Hyperoside
2 Sulforaphane (mainly Broccoli)
2 Juglone
2 Kaempferol
2 L-Theanine
2 Licochalcone A
2 SDG/lignans
2 Luteolin
2 capecitabine
2 Mangiferin
2 Methylsulfonylmethane
2 Mushroom Chaga, Inonotus obliquus
2 Naringin
2 Terpinen-4-ol / Tea Tree Oil
2 Aflavin-3,3′-digallate
1 1,8-Cineole
1 3-bromopyruvate
1 Açaí, Euterpe oleracea
1 chemodynamic therapy
1 wortmannin
1 Ajoene (compound of Garlic)
1 Alpha-Lipoic-Acid
1 low dose naltrexone
1 Artemisinin
1 Benzyl isothiocyanate
1 Brucea javanica
1 Bromelain
1 borneol
1 Vitamin D3
1 Boswellia (frankincense)
1 Black Rice, Oryza sativa
1 α-Bisabolol / Chamomile oil
1 Caffeine
1 Zinc
1 Capsaicin
1 Carvacrol
1 Cannabidiol
1 Celastrol
1 chaetocin
1 chitosan
1 Cucurbitacin
1 Oxaliplatin
1 Chlorella (Chlorella vulgaris)
1 SonoDynamic Therapy UltraSound
1 Cynaropicrin
1 Metformin
1 Bortezomib
1 Deguelin
1 diet FMD Fasting Mimicking Diet
1 diet Methionine-Restricted Diet
1 Diindolylmethane
1 Dandelion Root
1 Ginkgo biloba-EGb 761
1 Docetaxel
1 Emodin
1 Tetrahydroxystilbene glucoside
1 Electrical Pulses
1 Ferulic acid
1 Paclitaxel/Taxol
1 Flaxseed/Linseed
1 Fucoidan
1 Garcinol
1 Geraniol
1 Ginger/6-Shogaol/Gingerol
1 Ginseng
1 Graviola
1 HydroxyCitric Acid
1 Hyperthermia
1 Indole-3-carbinol
1 iodine
1 phytic acid, Inositol hexakisphosphate
1 Isothiocyanates
1 Isovitexin
1 Lasiodin
1 Licorice
1 Lemongrass Extract/Citral
1 Lycopene
1 Magnolol
1 Matrine
1 Modified Citrus Pectin
1 methylseleninic acid
1 Lemon Balm/Melissa officinalis
1 Morin
1 tamoxifen
1 Mistletoe/Viscum album Extracts
1 Helleborus niger extracts – Christmas Rose
1 Mushroom Lion’s Mane, Hericium erinaceus
1 Bicarbonate(Sodium)
1 Patchouli Oil (Pogostemon cablin)
1 Phenylbutyrate
1 Phycocyanin
1 Piperine
1 probiotics
1 Pterostilbene
1 enzalutamide
1 Resveratrol
1 Rutin
1 salinomycin
1 α-Santalol/Sandalwood oil
1 Selenium
1 Oxygen, Hyperbaric
1 Sesamin
1 Iron
1 Salvia miltiorrhiza
1 Thymol-Thymus vulgaris
1 Magnesium
1 Vitamin K2
1 Walnut
1 Xylitol
1 Zerumbone
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:530  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page